Ionis Pharmaceuticals Inc (IONS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -9.264 | -0.534 | 13.722 | 9.97 | -16.052 | -1.144 | -10.484 | -13.262 |
Return on Equity (%) | -57.636 | -2.304 | 34.092 | 20.486 | -35.705 | -3.541 | -40.119 | -76.344 |
Return on Invested Capital (%) | -7.069 | 4.061 | 27.421 | 18.245 | -33.165 | -1.636 | -23.15 | -24.946 |
Operating Margin (%) | -12.933 | 4.23 | -5.231 | 35.234 | -17.146 | -2.443 | -42.54 | -32.059 |
Net Profit Margin (%) | -24.971 | -1.176 | 45.648 | 26.202 | -61.882 | -3.529 | -45.921 | -46.504 |
Book Value Per Share | 0.651 | 3.174 | 8.432 | 11.819 | 5.809 | 5.259 | 4.032 | 2.695 |
Earnings Per Share | -0.712 | -0.048 | 1.984 | 2.096 | -3.215 | -0.202 | -1.899 | -2.553 |
Cash Per Share | 0.696 | 1.037 | 2.021 | 4.868 | 2.833 | 6.155 | 1.946 | 2.783 |
Working Capital Per Share | 5.46 | 7.547 | 13.974 | 17.439 | 11.024 | 14.902 | 13.311 | 15.289 |
Operating Profit Per Share | 2.849 | 4.062 | 4.334 | 7.967 | 5.125 | 5.679 | 4.052 | 5.444 |
EBIT Per Share | -0.687 | -0.186 | -0.552 | 2.471 | -1.211 | -0.206 | -1.816 | -2.328 |
EBITDA Per Share | -0.687 | -0.186 | -0.552 | 2.471 | -1.211 | -0.206 | -1.816 | -2.328 |
Free Cash Flow Per Share | -0.691 | 0.188 | 2.022 | 2.24 | -3.032 | -0.202 | -1.875 | -2.447 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 121,64M | 124,98M | 137,93M | 140,34M | 140,37M | 141,21M | 142,06M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 142,06M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -73.412 | N/A | N/A | N/A | -100.938 | N/A | N/A |
Net Profit Margin (%) | N/A | -95.249 | N/A | N/A | N/A | -119.503 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 5,84B |
Ratio cours/bénéfice | -15,78 |
Ratio prix/ventes | 7,34 |
Ratio prix/liquidités | 14,48 |
Ratio prix/valeur comptable | 14,95 |
Rendement de dividende | - |
Actions en circulation | 157,9M |
Volume moyen (1 semaine) | 1,45M |
Volume moyen (1 mois) | 1,6M |
Variation sur 52 semaines | -25,82% |
Plus haut sur 52 semaines | 54,4446 |
Plus bas sur 52 semaines | 33,33 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales